Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples

By LabMedica International staff writers
Posted on 03 Sep 2026

Peripheral blood mononuclear cells (PBMCs) are widely used to monitor infection, autoimmunity, cancer, and treatment response, yet most assays depend on fluorescent labels that can perturb cells and provide limited functional insight. More...

Measuring immune-cell metabolism nondestructively has remained a diagnostic challenge. Functional readouts at single-cell resolution could sharpen interpretation of immune dynamics in blood. New findings demonstrate a label-free optical approach that gauges immune-cell metabolic activity directly within mixed PBMC samples.

At the Morgridge Institute for Research (Madison, WI, USA), investigators used optical metabolic imaging (OMI) to interrogate immune-cell function without extrinsic dyes. The method excites endogenous metabolic cofactors with two-photon microscopy and measures the time these molecules emit light, generating fluorescence lifetime signatures that correlate with cellular activation state. Because OMI relies on native signals, analyzed cells remain viable for subsequent testing.

The study examined PBMCs isolated from three healthy donors and analyzed thousands of individual cells in resting and activated states. Researchers applied machine-learning algorithms to determine whether metabolic measurements alone could identify immune-cell subtypes and detect early activation within heterogeneous blood samples. The single-cell approach captured metabolic heterogeneity that would be obscured by bulk measurements.

OMI distinguished activated from resting PBMCs with nearly 94% accuracy just two hours after stimulation. In resting samples, monocytes were identified with 96% accuracy and with 88% accuracy after activation, while natural killer (NK) cells were identified with approximately 74% accuracy in both states. By contrast, T cells and B cells displayed more similar metabolic profiles under the experimental conditions, reflecting less distinctive signatures in this framework.

According to the release, the technique is currently a research tool and does not yet match the accuracy of established labeling methods for identifying every immune-cell subtype. The work, published in Biophotonics Discovery on September 1, 2026, also notes opportunities to enhance deployment by pairing advanced biophotonic imaging with machine learning for broader studies of immune function in health and disease.

Related Links
Morgridge Institute for Research
University of Wisconsin–Madison


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.